Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1221443-94-2

Post Buying Request

1221443-94-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1221443-94-2 Usage

General Description

The chemical compound "(R)-1-(7-chloro-2,2-bis(fluoromethyl)-chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea" is a complex organic molecule with a specific stereochemical arrangement. It contains a chroman-4-yl group, which is a type of benzopyran derivative, as well as a 3-(3-methylisoquinolin-5-yl)urea group. (R)-1-(7-chloro-2,2-bis(fluoromethyl)-chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea likely has potential biological activity due to its structural features, and may have applications in medicinal chemistry or as a research tool in the study of biochemical processes. Its precise mechanism of action and potential uses would need to be investigated through further research and experimentation.

Check Digit Verification of cas no

The CAS Registry Mumber 1221443-94-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,1,4,4 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1221443-94:
(9*1)+(8*2)+(7*2)+(6*1)+(5*4)+(4*4)+(3*3)+(2*9)+(1*4)=112
112 % 10 = 2
So 1221443-94-2 is a valid CAS Registry Number.

1221443-94-2Downstream Products

1221443-94-2Relevant articles and documents

Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (a-1165442): A temperature-neutral transient receptor potential vanilloid-1 (trpv1) antagonist with analgesic efficacy

Voight, Eric A.,Gomtsyan, Arthur R.,Daanen, Jerome F.,Perner, Richard J.,Schmidt, Robert G.,Bayburt, Erol K.,Didomenico, Stanley,McDonald, Heath A.,Puttfarcken, Pamela S.,Chen, Jun,Neelands, Torben R.,Bianchi, Bruce R.,Han, Ping,Reilly, Regina M.,Franklin, Pamela H.,Segreti, Jason A.,Nelson, Richard A.,Su, Zhi,King, Andrew J.,Polakowski, James S.,Baker, Scott J.,Gauvin, Donna M.,Lewis, Lageisha R.,Mikusa, Joseph P.,Joshi, Shailen K.,Faltynek, Connie R.,Kym, Philip R.,Kort, Michael E.

, p. 7412 - 7424 (2014)

The synthesis and characterization of a series of selective, orally bioavailable 1-(chroman-4-yl)urea TRPV1 antagonists is described. Whereas first-generation antagonists that inhibit all modes of TRPV1 activation can elicit hyperthermia, the compounds disclosed herein do not elevate core body temperature in preclinical models and only partially block acid activation of TRPV1. Advancing the SAR of this series led to the eventual identification of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442, 52), an analogue that possesses excellent pharmacological selectivity, has a favorable pharmacokinetic profile, and demonstrates good efficacy against osteoarthritis pain in rodents.

TRPV1 ANTAGONISTS

-

Page/Page column 91, (2010/04/30)

Disclosed herein are compounds of Formula (I), or pharmaceutically acceptable salts, solvates, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and m are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1221443-94-2